Reneuron Share Discussion Threads

[stewart_25] 15/6/2016 08:37

7th July - my birthday - great news and a massive rise in share price - what more could I ask for as a birthday present?

[hutch_pod] 13/6/2016 15:21

So a slippage to Q4 for the Phase II stroke results..

Haven't the hRPC and exosome programmes slipped a tad too?

[fredd1eboy] 10/6/2016 08:34

BBC Breakfast his morning.
Potential for stem cells in new chemo treatment research.
Involves destroying immune system and rebuilding with stem cells. Possibly appropriate for MS.
Watch this space!

[norbus] 09/6/2016 22:51

That's what she said! In the 1990's it was a pipkin so if flew on a fart. Market wary, and the reality round the corner can never be foretold. I worry about the Cancer work announced as a new string

[dickbush] 09/6/2016 14:32

Very good news flow this week and the share price hasn't budged. In the late 1990's this stock would have been many multiples of this price. As it is, the market is in a "show me" mood, quite rightly IMO.

[stewart_25] 09/6/2016 11:40

Hope you are right Freddie... could do with the share price looking a lot brighter to lift my confidence

[fredd1eboy] 09/6/2016 10:36

Im so pleased Reneuron has found a 1st class partner to develop this fantastic technology. It worked miraculously on rats causing consistant imploding of the cancer mass within days. It will take time for the market to fully appreciate the potential of Reneurons exosome which is a free bye product of the stem cell manufacturing process (olavs gold dust).
Once the current funding has been recognized by the market the penny will drop. Takes financial whiz kids a fews days to work out value based on non sterling measures. Reassurance will be required from cross over professionals and media. Give it a few days to sink in. Freddie

[stewart_25] 09/6/2016 09:06

mm - two positive(ish) RNS out in two days - and the share price - flat...

[easwarareddy] 09/6/2016 07:27

Oow another way that is going to make us rich. Rns out

[stewart_25] 07/6/2016 11:17

if so this was the safety trial data, not efficacy....

[elgordo] 07/6/2016 08:47

I think that is the second time in a few days that the article that starts "Five stroke victims have shown small signs of recovery following pioneering stem cell therapy..." has been posted here. Be aware that this article dates back to May 2013.

[norbus] 07/6/2016 06:54

withdrawn, based on out of date link as pointed out

[stewart_25] 06/6/2016 15:30

and barely a movement in the share price ..

[goyathlay] 05/6/2016 17:50

This was from yesterday and features a patient and his progress. Encouraging.

[peawacks] 03/6/2016 17:43

Five stroke victims have shown small signs of recovery following pioneering stem cell therapy.

Prof Keith Muir, of Glasgow University, said the results were "not what we would have expected" from the group of patients who had previously shown no indications of their conditions improving.

The trial involved injecting stem cells directly into the damaged parts of the patients' brains, with the hope that they would turn into healthy tissue or "kick-start" the body's own repair processes.

The study involved patients who suffered strokes some time ago and had shown no signs of making any further spontaneous improvement.

Prof Muir said the results were "at the present time not what we would have expected in this group but far from being able to say whether it's something specifically related to the cells".

He said: "We remain pleased and encouraged by the data emerging from the PISCES study. The data to date identify no safety issues with the ReN001 treatment – which is the primary focus of this Phase I trial.

"The evidence of functional improvement requires further investigation in a suitably designed Phase II efficacy study and we look forward to being a principal clinical site in that study when it commences."

The stem cells were created 10 years ago from one sample of nerve tissue taken from a foetus.

Scientists said the PISCES study is the world's first clinical trial examining the safety of neural stem cell treatment in stroke patients.

The first phase of the research focused on whether there were any safety concerns about the treatment.

The initial results will be presented at the European Stroke Conference in London, with full results due to be published next year.

Plans for a second phase, which will further explore how effective the treatment is, are due to be submitted to UK regulators in early July.

Around 20 patients will take part if it is approved, all of whom will have suffered a stroke within a few weeks.
STV

[fredd1eboy] 03/6/2016 16:20

Curtesy oilprince iii site.
Rene mentioned today on BBC
Well, sort of mentioned anyway. This lunchtime's BBC Look North had a VERY brief interview with a consultant at a hospital in Newcastle explaining they'd recruited the first patient for a new stem-cell treatment for strokes.
Reneuron was given no mention at all but I'm pretty sure it is RENE that is involved with a Newcastle hospital.
I think you may be able to view the clip on the BBC website but I'm not too sure.
It's annoying that this American company is getting all the coverage (Daily Mail today too!) But as someone who is suffering the effects of two Strokes I am very encouraged by all the successful
results of treatments that seem to be heading for use by all that need them.

[fredd1eboy] 03/6/2016 16:16

Well done Esmerelda. Hoping for a restoration back to 5/6p prior to news.
Just need to get the 3p ish sellers shares sold and back to a good home via mms in meantime.
Best wishes. Freddie

[esmerelda] 03/6/2016 15:01

Surely an indication by end Q2 (unless you meant 2017!) is good news as that is about four weeks away fredd1eboy? Just bought a few more just in case :-)

[fredd1eboy] 03/6/2016 11:43

Sounds good dogwalker. Heres hoping and keep in touch. Best wishes Freddie

[dogwalker] 03/6/2016 11:05

On the positive side, fredd1eboy, maybe we've just touched support in an uptrend dating from 8/12/15, with a lot more to go.

[dogwalker] 03/6/2016 08:52

'There are around 30 similar trials in progress'. That's interesting. I wonder which the companies are doing them. Let's hope we get there , say, somewhere in the first three or four? First would be nice with something that worked.
(How would you feel about being one of the placebo triallers being given just a hole in the head?!)